Product image of Methotrexate Afortas (Methotrexate) supplied by GNH India

Methotrexate Afortas

Active Ingredient:
Methotrexate
Origin:
EU

Methotrexate Afortas (Methotrexate)

Methotrexate, the active ingredient in Methotrexate Afortas, is an antimetabolite (folate antagonist) presented as an oral tablet for oral use. It is employed in the management of rheumatoid arthritis, psoriasis, certain leukemias and lymphomas, and in the medical treatment of ectopic pregnancy.

GNH India supplies Methotrexate Afortas as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory‑compliant shipments to qualified healthcare institutions.

Manufacturer / TM Owner

2care4 Generics Aps

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Methotrexate Afortas is used as a disease‑modifying antirheumatic drug and antineoplastic agent across several clinical pathways.

  • Rheumatoid arthritis: reduces joint inflammation and slows disease progression.
  • Psoriasis: diminishes skin lesions and plaque formation.
  • Certain leukemias and lymphomas: interferes with malignant cell proliferation.
  • Ectopic pregnancy (medical management): terminates trophoblastic tissue non‑surgically.

How It Works

  • Methotrexate inhibits dihydrofolate reductase, preventing the regeneration of tetrahydrofolate. This blockade reduces the synthesis of purine and pyrimidine nucleotides, thereby impairing DNA, RNA, and protein production in rapidly dividing cells, including immune cells and malignant clones.

Side Effects

Methotrexate Afortas may cause a range of adverse reactions, which are categorized by frequency and severity.

Common Side Effects

  • Nausea and vomiting.
  • Fatigue and malaise.
  • Oral mucosal ulceration.
  • Transient elevation of liver enzymes.
  • Mild alopecia.
  • Decreased white blood cell count.

Serious or Rare Side Effects

  • Severe hepatotoxicity or fibrosis.
  • Pulmonary fibrosis or interstitial pneumonitis.
  • Profound bone marrow suppression leading to pancytopenia.
  • Opportunistic infections.
  • Acute renal failure.
  • Life‑threatening cutaneous reactions such as Stevens‑Johnson syndrome.

Precautions & Warnings

When prescribing Methotrexate Afortas, clinicians should observe several safety precautions to minimize risk.

  • Pregnancy: contraindicated (Category X) – avoid use in pregnant patients.
  • Renal function: assess baseline and monitor renal parameters regularly.
  • Liver function: perform periodic liver enzyme tests.
  • Hematologic monitoring: obtain complete blood counts before and during therapy.
  • Drug interactions: review concomitant medications for potential interactions.
  • Store at ambient temperature: keep in original container, protect from moisture and light.

Avoid Interactions

Methotrexate Afortas interacts with several medicines that can alter its efficacy or toxicity.

Major Interactions (Avoid)

  • NSAIDs: increase risk of gastrointestinal toxicity and renal impairment.
  • Penicillins (e.g., amoxicillin): may reduce methotrexate clearance.
  • Proton pump inhibitors: can raise methotrexate serum concentrations.
  • Live vaccines: heightened risk of severe infection.
  • Trimethoprim‑sulfamethoxazole: potentiates bone‑marrow suppression.

Moderate Interactions (Monitor Closely)

  • Azathioprine: additive immunosuppression.
  • Sulfasalazine: may increase hepatotoxicity.
  • Folic acid supplements: can diminish efficacy if not timed correctly.
  • Alcohol: may exacerbate liver toxicity.
  • Cytarabine: additive myelosuppression.

Frequently Asked Questions

Methotrexate Afortas is indicated for rheumatoid arthritis, plaque psoriasis, certain leukemias and lymphomas, and for the medical management of ectopic pregnancy. It acts as a disease‑modifying antirheumatic drug and an antineoplastic agent in these settings.

Methotrexate blocks the enzyme dihydrofolate reductase, which is essential for producing tetrahydrofolate. This inhibition reduces the synthesis of nucleotides needed for DNA, RNA, and protein formation, thereby limiting the proliferation of rapidly dividing cells such as immune cells and cancer cells.

The appropriate dose of Methotrexate Afortas is individualized by the prescribing clinician based on the specific indication, disease severity, patient weight, renal and hepatic function, and response to therapy. No fixed regimen is provided here.

Methotrexate is classified as Pregnancy Category X, meaning it is contraindicated in pregnancy due to a high risk of fetal malformations and miscarriage. It is also not recommended while breastfeeding because it can be excreted in breast milk and harm the infant.

To order, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain needs) and required import documentation.

Methotrexate is often considered the first‑line disease‑modifying antirheumatic drug because of its proven efficacy and cost‑effectiveness. Compared with agents like leflunomide or biologic therapies, methotrexate has a well‑characterized safety profile but may require regular monitoring of liver and blood parameters.

Store Methotrexate Afortas at ambient temperature, below 25 °C, in the original packaging. Protect the tablets from moisture, excessive heat, and direct sunlight to maintain stability.

Methotrexate Afortas is taken orally as a tablet with a full glass of water. Depending on the clinical protocol, it may be taken with or without food, and folic acid supplementation is often advised to reduce mucosal toxicity.

Serious risks include severe liver toxicity, pulmonary fibrosis, profound bone‑marrow suppression leading to pancytopenia, and acute renal failure. Patients should be educated to report symptoms such as persistent fatigue, shortness of breath, jaundice, or unusual bruising promptly.

Methotrexate Afortas should be avoided in pregnant women, individuals with severe renal or hepatic impairment, patients with uncontrolled infections, and those with known hypersensitivity to methotrexate or any of its excipients.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Methotrexate

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT